Home > Insider Trading > Filing (0001181431-12-049045)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
891288	Questcor Pharmaceuticals Inc	QCOR	Pharmaceutical Preparations (2834)	330476164

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1097955	Md J Mitchell Blutt	1300 North Kellogg Drive Suite D Anaheim CA 92807		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-09-04	6,968	$10.16	6,968	No	4	M	Direct
Common Stock	Acquisiton	2012-09-04	7,762	$14.73	14,730	No	4	M	Direct
Common Stock	Disposition	2012-09-04	14,730	$47.60	0	No	4	S	Direct
Common Stock	Disposition	2012-09-04	10,000	$47.60	220,000	No	4	S	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2012-09-04	4,885	$0.00	4,885	$10.16
Common Stock	Stock Option (right to buy)	Disposition	2012-09-04	2,083	$0.00	2,083	$10.16
Common Stock	Stock Option (right to buy)	Disposition	2012-09-04	7,762	$0.00	7,762	$14.73

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2020-06-30	No	4	M	Direct
11,459	2020-06-30	No	4	M	Direct
2,238	2020-12-31	No	4	M	Direct

Footnotes

Options were granted under the Questcor Pharmaceuticals, Inc. 2004 Non-Employee Director's Stock Option Plan.
The option was granted on 07/01/2010 for the right to buy 5,000 shares of common stock of the Issuer. The option was fully vested at the time of the grant.
The option was granted on 07/01/2010 for the right to buy 25,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant.
The option was granted on 01/01/2011 for the right to buy 10,000 shares of common stock of the Issuer. The option was fully vested at the time of the grant.
The reported securities are directly owned by Consonance Capital Master Account, L.P. and may be deemed beneficially owned by Consonance Capital Advisors, L.P., of which Dr. Blutt is the managing member. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.